New drug trial targets lung Cancer's resistance to leading treatment
NCT ID NCT06868485
Summary
This study is testing an experimental drug called WSD0922-FU for people with advanced non-small cell lung cancer. It is for patients whose cancer has started growing again after initial treatment with the drug osimertinib and who have a specific genetic change (C797S mutation) in their tumor. The main goal is to see if this new drug can shrink tumors and control the cancer's progression.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU Bordeaux - Centre Francois Magendie
RECRUITINGPessac, Nouvelle-Aquitaine, 33604, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU Toulon - Hopital Sainte Musse
RECRUITINGToulon, Var, 83100, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Centre Francois Baclesse
RECRUITINGCaen, Normandy, 14000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Centre Hospitalier Universitaire (CHU) de Rennes - Hopital de Pontchaillou
RECRUITINGRennes, Ille-et-Vilaine, 35000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Centre Hospitalier Universitaire CHU De Limoges
RECRUITINGLimoges, Nouvelle-Aquitaine, 87042, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Cleveland Clinic
RECRUITINGCleveland, Ohio, 44195, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Cleveland Clinic Weston Hospital
RECRUITINGWeston, Florida, 33331, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
FOMAT Oncology
RECRUITINGOxnard, California, 93030, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Fujian Provincial Cancer Hospital
RECRUITINGFuzhou, Fujian, 350014, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hackensack Meridian Health-Southern Ocean Medical Center
RECRUITINGManahawkin, New Jersey, 08050, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Karmanos Cancer Institute
RECRUITINGDetroit, Michigan, 48201, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Shanghai East hospital
RECRUITINGShanghai, Shanghai Municipality, 200120, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Shanghai Pulmonary Hospital
RECRUITINGShanghai, Shanghai Municipality, 200433, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Tianjin Medical University Cancer Institute and Hospital
RECRUITINGTianjin, Tianjin Municipality, 300202, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
TxO Central/South, Texas Oncology -Central/South Texas
RECRUITINGAustin, Texas, 78745, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
UPMC Hillman Cancer Center
RECRUITINGPittsburgh, Pennsylvania, 15235, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Virginia Cancer Specialists
RECRUITINGFairfax, Virginia, 22031, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Wuhan Union Hospital
RECRUITINGWuhan, Hubei, 430022, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.